Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,040 | -83,938 | -119,763 | -82,084 | -39,714 |
| Depreciation Amortization | 808 | 504 | 2,465 | 2,071 | 1,564 |
| Accounts payable and accrued liabilities | 941 | 527 | -2,792 | 1,471 | 153 |
| Other Working Capital | -6,203 | -1,261 | -1,808 | 36,467 | -1,525 |
| Other Operating Activity | 43,988 | 65,257 | 66,725 | 3,907 | 16,080 |
| Operating Cash Flow | $-41,506 | $-18,911 | $-55,173 | $-38,168 | $-23,442 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 13,872 | 13,872 | 13,872 |
| Investing Cash Flow | $N/A | $N/A | $13,872 | $13,872 | $13,872 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114,116 | 115,808 | 74,854 | 44,943 | 27,911 |
| Other Financing Activity | -311 | -311 | -312 | 153 | 618 |
| Financing Cash Flow | $113,805 | $115,497 | $74,542 | $45,096 | $28,529 |
| Beginning Cash Position | 49,898 | 49,898 | 16,657 | 16,657 | 16,657 |
| End Cash Position | 122,197 | 146,484 | 49,898 | 37,457 | 35,616 |
| Net Cash Flow | $72,299 | $96,586 | $33,241 | $20,800 | $18,959 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,506 | -18,911 | -55,173 | -38,168 | -23,442 |
| Free Cash Flow | -41,506 | -18,911 | -55,173 | -38,168 | -23,442 |